The Mpox vaccine, also called monkeypox, starts this Monday (13). According to the Ministry of Health, 47,000 doses will be distributed among all states and the federal district.

The campaign will use the Jynneos/Imvanex vaccine and as there is a dose limit, application will continue as long as supplies last. Information taken from R7.

The Ministry of Health plans to apply the vaccine to about 16,000 people – Photo: Freepik

The ministry classifies the vaccine as a “live vaccine”. “Derived from a modified strain of Vaccinia Ankara-Bavarian Nordic (MVA-BN), an attenuated and non-replicating orthopoxvirus against smallpox and monkeypox that elicits a humoral and cellular immune response against orthopoxviruses,” he explains in a note.

According to the folder, the vaccination schedule will consist of two doses (0.5 ml each) four weeks (28 days) apart for individuals over 18 years of age, to be offered to specific groups before and after exposure.

The health ministry told Agência Brasil that the public initially intended to administer the vaccine to around 16,000 people.

See below for vaccination requirements:

Suitable groups for pre-exposure vaccination

• People with HIV/AIDS: cisgender men, transvestites, and transgender women aged 18 years or older with an immunological status defined by a CD4 T-lymphocyte count of less than 200 cells in the past six months;
• Laboratory professionals working directly with orthopoxvirus in biosafety level 3 (BSL-3) laboratories, ages 18 to 49.

Groups eligible for post-exposure vaccination

Persons who have had direct contact with body fluids and secretions of persons with suspected, probable or confirmed presence of nitric oxide, whose exposure is classified as high risk (direct contact of skin or mucous membranes with skin or respiratory secretions) or moderate risk (no direct contact, but close , in the same room or indoors).